BioCentury
ARTICLE | Distillery Therapeutics

Neurology

January 18, 2017 7:06 PM UTC

In vitro and rat studies suggest agonizing the GRIN2A signaling pathway could help treat age-related cognitive dysfunction. In brain slices from a rat model of the disease, a tool compound that agoniz...